Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy | Zendy

Natasha K. Martin | Zendy; Matthew Hickman | Zendy; Sharon Hutchinson | Zendy; David Goldberg | Zendy; Peter Vickerman | Zendy

Open Access

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

Author(s) -

Natasha K. Martin,

Matthew Hickman,

Sharon Hutchinson,

David Goldberg,

Peter Vickerman

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit296

Subject(s) - medicine , syringe , hepatitis c , psychological intervention , incidence (geometry) , opiate substitution treatment , transmission (telecommunications) , hepatitis c virus , antiviral therapy , chronic hepatitis , immunology , virus , buprenorphine , physics , receptor , electrical engineering , psychiatry , opioid , optics , engineering

Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatment may prevent onward transmission. We project the impact of combining OST, HCNSP, and antiviral treatment on HCV prevalence/incidence among PWID.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research